What is the workup for leukocytosis (elevated white blood cell count) of unknown etiology?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Leukocytosis of Unknown Etiology

The workup for leukocytosis of unknown etiology should include a complete blood count with differential, peripheral blood smear examination, comprehensive metabolic panel, bone marrow aspiration and biopsy with cytogenetic and molecular studies, and targeted imaging based on clinical suspicion. 1

Initial Laboratory Evaluation

  • Complete Blood Count (CBC) with differential

    • Assess absolute counts of different WBC types (neutrophils, lymphocytes, monocytes, eosinophils, basophils)
    • Calculate neutrophil-to-lymphocyte ratio as a marker of inflammation severity
    • Evaluate for presence of immature forms ("left shift") - band counts >1,500 cells/mm³ strongly suggest bacterial infection (likelihood ratio 14.5) 1
  • Peripheral Blood Smear

    • Examine for morphological abnormalities in WBCs
    • Look for blast cells, dysplastic changes, or abnormal cell populations
    • Assess for concurrent abnormalities in red blood cells and platelets
  • Comprehensive Metabolic Panel

    • Evaluate liver and kidney function
    • Check serum uric acid and lactate dehydrogenase (LDH) which have prognostic relevance 2
  • Inflammatory Markers

    • C-reactive protein (CRP) and procalcitonin (PCT) to help distinguish infection from other causes 1
    • PCT rises and clears more quickly than CRP and correlates better with sepsis severity

Bone Marrow Studies

  • Bone Marrow Aspiration and Biopsy

    • Indicated when peripheral blood findings suggest a primary hematologic disorder
    • Essential for diagnosis of leukemia and myeloproliferative disorders
    • Should include:
      • Morphologic examination
      • Cytochemistry
      • Immunophenotyping
      • Cytogenetic analysis 2
  • Molecular and Genetic Studies

    • Cytogenetic analysis (karyotype with fluorescence in situ hybridization) 2
    • Molecular testing for specific mutations based on suspected diagnosis:
      • For suspected AML: FLT3-ITD, NPM1, CEBPA, IDH1/IDH2, RUNX1, ASXL1, TP53 2
      • For suspected ALL: BCR-ABL1, KMT2A (MLL) gene translocation 2
      • For suspected CMML: NRAS, KRAS, TET2, CBL, SRSF2 genes 2

Imaging Studies

  • Chest Imaging

    • Chest X-ray to screen for infection or malignancy
    • CT scan of chest for patients with suspected T-cell ALL or if thoracic infection/malignancy is suspected 2
  • Abdominal Imaging

    • Ultrasound or CT scan of abdomen if hepatosplenomegaly is suspected or to assess for lymphadenopathy
    • Particularly important if fungal infection is suspected 2
  • PET/CT

    • Recommended if extramedullary disease is suspected 2

Special Considerations

  • Infectious Disease Workup

    • Blood cultures if infection is suspected
    • Specific cultures based on clinical presentation
    • Consider viral studies if lymphocytosis predominates
  • Cerebrospinal Fluid Analysis

    • Indicated in patients with neurological symptoms or if acute leukemia is diagnosed
    • Should include cell count, cytology, and flow cytometry 2
  • Cardiac Evaluation

    • Echocardiogram recommended for patients with risk factors or history of heart disease 2
    • Particularly important if treatment with anthracyclines is anticipated

Diagnostic Algorithm

  1. Determine if leukocytosis is reactive or primary:

    • WBC >100,000/μL strongly suggests a primary bone marrow disorder and represents a medical emergency 3
    • Presence of blast cells, significant dysplasia, or concurrent cytopenias suggests primary disorder
    • History of recent infection, inflammation, stress, or medications suggests reactive cause
  2. For suspected reactive leukocytosis:

    • Identify and treat underlying cause (infection, inflammation, medication effect)
    • Monitor WBC count for resolution with treatment of primary condition
    • If leukocytosis persists despite resolution of apparent cause, proceed to bone marrow evaluation
  3. For suspected primary hematologic disorder:

    • Urgent hematology consultation
    • Proceed directly to bone marrow studies and molecular testing
    • HLA typing should be performed if allogeneic stem cell transplantation might be considered 2

Common Pitfalls to Avoid

  • Assuming normal WBC count excludes infection - other markers like CRP or PCT may be more helpful 1
  • Attributing leukocytosis solely to stress without excluding infection - clinical context is crucial 1
  • Failure to recognize extreme leukocytosis (>100,000/μL) as a medical emergency requiring immediate intervention 3
  • Overlooking medication effects - corticosteroids, lithium, beta-agonists, and epinephrine can cause leukocytosis 1
  • Initiating antibiotics before obtaining appropriate cultures - this may obscure the diagnosis 1
  • Neglecting to evaluate the peripheral blood smear - this is essential for initial assessment of leukocytosis 4

Remember that persistent unexplained leukocytosis warrants thorough investigation, as it may represent an early sign of a serious underlying condition. The workup should be systematic and comprehensive to avoid missing potentially life-threatening diagnoses.

References

Guideline

Interpretation of White Blood Cell Count

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Leukocytosis: basics of clinical assessment.

American family physician, 2000

Research

Why does my patient have leukocytosis?

Hematology/oncology clinics of North America, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.